Abstract
Myocyte enhancer factor 2C (MEF2C) encodes a transcription factor which is ectopically expressed in T-cell acute lymphoblastic leukemia (T-ALL) cell lines, deregulated directly by ectopically expressed homeodomain protein NKX2-5 or by loss of promoter regions via del(5)(q14). Here, we analyzed the MEF2C 5'-region, thus identifying potential regulatory binding sites for GFI1B, basic helix-loop-helix proteins, STAT5, and HOXA9/HOXA10. Chromatin immunoprecipitation and overexpression analyses demonstrated direct activation by GFI1B and LYL1 and inhibition by STAT5. HOXA9/HOXA10 activated expression of NMYC which in turn mediated MEF2C repression, indicating an indirect mode of regulation via NMYC interactor (NMI) and STAT5. Lacking comma: Chromosomal deletion of the STAT5 binding site in LOUCY cells reduced protein levels of STAT5 in some MEF2C-positve T-ALL cell lines, and the presence of inhibitory IL7-JAK-STAT5 signaling highlighted the repressive impact of this factor in MEF2C regulation. Taken together, our results indicate that the expression of MEF2C in T-ALL cells is principally deregulated via activating leukemic transcription factors GFI1B or NKX2-5 and by escaping inhibitory developmental STAT5 signaling.
MeSH terms
-
Basic Helix-Loop-Helix Transcription Factors / antagonists & inhibitors
-
Basic Helix-Loop-Helix Transcription Factors / genetics
-
Basic Helix-Loop-Helix Transcription Factors / metabolism
-
Blotting, Western
-
Chromatin Immunoprecipitation
-
Gene Expression Regulation, Neoplastic*
-
Homeobox A10 Proteins
-
Homeobox Protein Nkx-2.5
-
Homeodomain Proteins / antagonists & inhibitors
-
Homeodomain Proteins / genetics
-
Homeodomain Proteins / metabolism
-
Humans
-
MADS Domain Proteins / genetics*
-
MADS Domain Proteins / metabolism*
-
MEF2 Transcription Factors
-
Myogenic Regulatory Factors / genetics*
-
Myogenic Regulatory Factors / metabolism*
-
Neoplasm Proteins / antagonists & inhibitors
-
Neoplasm Proteins / genetics
-
Neoplasm Proteins / metabolism
-
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma / genetics*
-
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma / metabolism
-
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma / pathology
-
Promoter Regions, Genetic / genetics*
-
Proto-Oncogene Proteins / antagonists & inhibitors
-
Proto-Oncogene Proteins / genetics
-
Proto-Oncogene Proteins / metabolism
-
Proto-Oncogene Proteins c-myc / genetics
-
Proto-Oncogene Proteins c-myc / metabolism
-
RNA, Messenger / genetics
-
RNA, Small Interfering / genetics
-
Repressor Proteins / antagonists & inhibitors
-
Repressor Proteins / genetics
-
Repressor Proteins / metabolism
-
Reverse Transcriptase Polymerase Chain Reaction
-
STAT5 Transcription Factor / antagonists & inhibitors
-
STAT5 Transcription Factor / genetics
-
STAT5 Transcription Factor / metabolism
-
Transcription Factors / genetics
-
Transcription Factors / metabolism
-
Transcription, Genetic
-
Tumor Cells, Cultured
Substances
-
Basic Helix-Loop-Helix Transcription Factors
-
GFI1B protein, human
-
Homeobox A10 Proteins
-
Homeobox Protein Nkx-2.5
-
Homeodomain Proteins
-
LYL1 protein, human
-
MADS Domain Proteins
-
MEF2 Transcription Factors
-
MEF2C protein, human
-
Myogenic Regulatory Factors
-
NKX2-5 protein, human
-
Neoplasm Proteins
-
Proto-Oncogene Proteins
-
Proto-Oncogene Proteins c-myc
-
RNA, Messenger
-
RNA, Small Interfering
-
Repressor Proteins
-
STAT5 Transcription Factor
-
Transcription Factors
-
homeobox protein HOXA9
-
HOXA10 protein, human